2nd Affiliated Hospital, School of Medicine
2nd Affiliated Hospital, School of Medicine
Hangzhou, Zhejiang, China8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study | non-small cell lung carcinoma | Recruiting | Phase 2 | 2026-07-07 | NCT07670013 | |
| Prophylactic Regimen With Intrathecal Thiotepa in SVZ-positive or Meningeal-risk Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-06 | NCT07511725 | |
| Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Recruiting | Phase 2 | 2026-03-30 | NCT07501026 | |
| Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, neoplasm, sarcoma | Not yet recruiting | Phase 2 | 2026-03-09 | NCT07457775 | |
| A Study Testing Emactinib Sulfate With Chemotherapy and Immunotherapy Before Surgery for Advanced Head and Neck Cancer | Head and Neck Cancer Squamous Cell Carcinoma | Recruiting | Phase 2 | 2026-03-09 | NCT07457346 | |
| Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), central nervous system cancer, epithelial neoplasm, glioblastoma, glioma, neoplasm, neoplastic meningitis, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor, tumor of meninges | Recruiting | Phase 2 | 2025-09-26 | NCT07193654 | |
| A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-09-26 | NCT07193641 | |
| Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-03-07 | NCT06863506 |